{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:10:03Z","timestamp":1756282203315,"version":"3.44.0"},"reference-count":6,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\n                  <jats:bold>Overview of:<\/jats:bold> Medicines and Healthcare products Regulatory Agency. Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure. <jats:italic>Drug Safety Update<\/jats:italic> 2023;16:1.<\/jats:p>","DOI":"10.1136\/dtb.2023.000019","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T13:20:25Z","timestamp":1681219225000},"page":"68-68","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Safety update: withdrawal of pholcodine-containing medicines"],"prefix":"10.1136","volume":"61","member":"239","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"2025082700420530000_61.5.68.1","first-page":"1","article-title":"Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure","volume":"16","year":"2023","journal-title":"Drug Safety Update"},{"key":"2025082700420530000_61.5.68.2","unstructured":"Pholcodine Linctus BP . Summary of product characteristics, UK. Pinewood Laboratories Ltd, 2022."},{"key":"2025082700420530000_61.5.68.3","unstructured":"Day & Night Nurse Capsules . Summary of product characteristics, UK. GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 2020."},{"key":"2025082700420530000_61.5.68.4","unstructured":"European Medicines Agency . Assessment report for pholcodine containing medicinal products [online]. 2012. Available: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/pholcodine-article-31-referral-assessment-report_en.pdf [Accessed 28 Mar 2023]."},{"key":"2025082700420530000_61.5.68.5","doi-asserted-by":"crossref","unstructured":"Mertes PM , Petitpain N , Tacquard C , et al . Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study. Br J Anaesth 2023:S0007-0912(23)00104-6. doi:10.1016\/j.bja.2023.02.026","DOI":"10.1016\/j.bja.2023.02.026"},{"key":"2025082700420530000_61.5.68.6","unstructured":"European Medicines Agency . Pholcodine-containing medicinal products [online]. 2023. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/pholcodine-containing-medicinal-products [Accessed 28 Mar 2023]."}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2023.000019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:42:15Z","timestamp":1756280535000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2023.000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":6,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,4,28]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/dtb.2023.000019"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2023.000019","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2023,4,11]]}}}